Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Weaning FailureAcute Respiratory Failure
Interventions
DEVICE

Optiflow (Fisher & Paykel Healthcare)

This device delivers high-flow oxygen through nasal cannula

DEVICE

Venturi mask

This device delivers low-flow oxygen at predetermined concentrations

Trial Locations (14)

Unknown

Sainte-Marguerite University Hospital, Marseille

Lapeyronie University Hospital, Montpellier

Saint Eloi University Hospital, Montpellier

La Pitie-Salpetriere University Hospital, Paris

Louis Mourier University Hospital, Paris

Saint-Louis University Hospital, Paris

University Hospital, Poitiers

Evangelismos University Hospital, Athens

Policlinico University Hospital, Bari

Università del Piemonte Orientale, Ospedale della Carità, Novara

Le Molinette University Hospital, Turin

Università del Piemonte Orientale, Sant'Andrea Hospital, Vercelli

Sant Pau University Hospital, Barcelona

00168

Catholic University of the Sacred Heart, A. Gemelli Hospital, Rome

All Listed Sponsors
collaborator

Fisher and Paykel Healthcare

INDUSTRY

lead

Catholic University of the Sacred Heart

OTHER

NCT02107183 - Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial | Biotech Hunter | Biotech Hunter